欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0341/001
药品名称
Orbeseal
活性成分
Bismuth Subnitrate 0.0 [no unit]
剂型
Intramammary suspension
上市许可持有人
Pfizer Ltd Ramsgate Road Sandwich Kent CT13 9NJ
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Orbeseal Dry Cow Intramammary Suspension
Germany (DE)
Denmark (DK)
Belgium (BE)
Orbeseal
Netherlands (NL)
Luxembourg (LU)
Austria (AT)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Norway (NO)
Finland (FI)
Bulgaria (BG)
Romania (RO)
Cyprus (CY)
Croatia (HR)
许可日期
2008/04/05
最近更新日期
2023/05/06
药物ATC编码
QG52X VARIOUS PRODUCTS FOR TEATS AND UDDER
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
annex-1-orbeseal-spc-clean-d30 (002)
Date of last change:2020/11/24
PAR
|
11951_PuAR_Anses2 2019 Final
Date of last change:2019/07/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase